全球血管成形術用氣球市場規模（按產品類型、應用、最終用戶、區域範圍和預測）

血管成形術用氣球的市場規模與預測

預計 2024 年血管成形術用氣球市值將達 20.5 億美元，2031 年將達到 26.2 億美元，2024 年至 2031 年的複合年成長率為 3.43%。

血管成形術用氣球是用於血管成形術的專用醫療設備。血管成形術是一種用於打開狹窄或阻塞的血管（尤其是動脈）並促進血流的技術。血管成形術用氣球最典型的用途是治療冠狀動脈疾病。冠狀動脈疾病是指向心臟供血的動脈因斑塊（由脂肪、膽固醇和其他化學物質混合物）的積聚而收縮。

血管成形術用氣球是治療冠狀動脈疾病的重要醫療設備。冠狀動脈疾病是指由心臟供血的動脈收縮或阻塞所引發的疾病。血管成形術用氣球最常見的用途是經經皮冠狀動脈擴張術(PTCA)，即將一根尖端帶有球囊的導管插入冠狀動脈狹窄區域。

隨著醫療技術的進步以及對改善心血管治療患者預後的日益重視，預計血管成形術用氣球經皮血管成形術用氣球越來越複雜，並根據每位患者的個性化需求進行客製化。

全球血管成形術用氣球市場動態

影響全球血管成形術用氣球市場的關鍵市場動態是：

關鍵市場促進因素

心血管疾病盛行率上升：血管成形術用氣球市場最重要的促進因素之一是全球心血管疾病 (CVD) 盛行率的上升。不良飲食習慣、久坐不動的生活方式以及人口老化導致冠狀動脈疾病、心臟病和動脈粥樣硬化的發病率不斷上升。

轉向微創手術：醫學界對微創手術的需求日益成長，而血管成形術正是順應這一趨勢的重要治療方法之一。微創手術之所以受到青睞，是因為與標準的開胸心臟手術相比，它們通常恢復時間更短、疼痛更少、併發症風險更低。血管成形術是一種微創手術，將帶有球囊的導管插入血管，到達阻塞部位，通常在局部麻醉下進行。

球囊設計技術進步：血管成形術用氣球設計和功能的不斷改進也是市場發展的關鍵驅動力。藥物塗層球囊能夠輸送藥物，防止動脈再次收縮，顯著提高了血管成形術的成功率。此外，用於治療疑難病變或鈣化病變的專用球囊的開發，也增加了受益於血管成形術的患者數量。

主要挑戰

球囊破裂風險：血管成形術用氣球最大的擔憂之一是治療過程中球囊破裂的可能性。如果球囊充氣超過斑塊，就可能發生破裂。破裂可能導致動脈損傷，需要進一步治療，甚至有心臟病發作的風險。

複雜病變導航困難：血管成形術球囊必須在冠狀動脈內導航才能到達阻塞源頭。複雜病變，例如彎曲、高度鈣化或曲折病變，會造成重大障礙。在這些情況下，球囊可能難以導航或充氣不均勻，導致治療不徹底或無效。

血管再阻塞和阻塞復發：血管成形術後，治療動脈有再次阻塞的風險。這可能是由於治療部位疤痕組織形成或斑塊再生所致。血管再阻塞是常見問題，可能需要重複治療或額外治療，例如置入術。

主要趨勢

技術進步：血管成形術用氣球產業已取得重大技術進步，並催生出高度專業化和高效的設備。藥物塗層球囊 (DCB) 和為提高性能而設計的尖端材料就是創新的典範。藥物塗層球囊在治療過程中將藥物直接輸送至動脈壁，旨在預防血管再阻塞血管再阻塞）。這項技術可改善血管成形術後患者的長期預後。

心血管疾病發生率上升：心血管疾病（CVD）發生率的上升推動了對血管成形術用氣球的需求。由於不良飲食、缺乏運動和肥胖率上升等生活方式因素，冠狀動脈疾病和周邊動脈疾病等心血管疾病的發生率日益上升。

專注於微創手術：醫學界對微創手術的需求日益成長，而血管成形術用氣球恰好契合了這一趨勢。微創手術相比標準手術方法具有許多優勢，包括恢復時間更短、潛在併發症更少以及術後疼痛更少。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概況
• 市場亮點

第3章 市場概況

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析

第4章血管成形術用氣球市場（依產品類型）

• 普通氣球
• 切割/球囊導管
• 藥物釋放型球囊（DEB）

第5章血管成形術用氣球市場（依應用）

• 冠狀動脈成形術
• 周邊血管成形術

第6章血管成形術用氣球市場（依最終用戶）

• 醫院
• 門診手術中心（ASC）
• 心導管實驗室

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機遇
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市佔率分析

第10章：公司簡介

• Medtronic
• Boston Scientific Corporation
• Cordis（Cardinal Health）
• Terumo Corporation
• BIOTRONIK

第11章 市場展望與機遇

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Angioplasty Balloons Market Size and Forecast

Angioplasty Balloons Market size was valued at USD 2.05 Billion in 2024 and is projected to reach USD 2.62 Billion by 2031, growing at a CAGR of 3.43% from 2024 to 2031.

Angioplasty balloons are specialized medical devices used in angioplasty, a technique that opens restricted or clogged blood vessels, particularly arteries, to enhance blood flow. The most typical application for angioplasty balloons is to treat coronary artery disease which occurs when the arteries that deliver blood to the heart constrict owing to plaque buildup a mixture of fat, cholesterol, and other chemicals.

Angioplasty balloons are critical medical equipment used to treat coronary artery disease which develops when the blood arteries that feed blood to the heart constrict or get blocked. The most prevalent application for angioplasty balloons is percutaneous transluminal coronary angioplasty (PTCA). This treatment involves inserting a balloon-tipped catheter into a constricted portion of the coronary artery.

The future usage of angioplasty balloons is expected to change dramatically driven by advances in medical technology and a rising emphasis on improving patient outcomes in cardiovascular treatment. Angioplasty balloons which are used to unblock blocked or restricted blood arteries during percutaneous coronary interventions (PCI) are becoming more complex and adapted to individual patient needs.

Global Angioplasty Balloons Market Dynamics

The key market dynamics that are shaping the global angioplasty balloons market include:

Key Market Drivers:

Rising Cardiovascular Disease Incidence: One of the most important drivers of the angioplasty balloons market is the global increase in cardiovascular illnesses (CVDs). Coronary artery disease, heart attacks, and atherosclerosis are on the rise as a result of poor diets, sedentary lifestyles, and an aging population.

Shift towards Minimally Invasive Procedures: In the medical world, there is an increasing demand for minimally invasive procedures, and angioplasty is one of the important treatments that fits this trend. Minimally invasive operations are preferred because they often have shorter recovery times, less pain, and a lower risk of problems than standard open-heart surgeries. Angioplasty which includes threading a balloon-tipped catheter through the blood vessels to the site of the blockage is a less invasive procedure that may often be done under local anesthesia.

Technological Advancements in Balloon Design: Constant improvements in the design and functionality of angioplasty balloons are another important market driver. Drug-coated balloons which deliver medication to assist prevent arteries from constricting again have considerably improved angioplasty outcomes. Furthermore, the development of specialty balloons such as those intended for use in difficult or calcified lesions has increased the number of patients who can benefit from angioplasty.

Key Challenges:

Risk of Balloon Rupture: One of the biggest issues with angioplasty balloons is the possibility of balloon rupture during the treatment. This can happen if the balloon is inflated above its intended pressure limit or if it comes into contact with a very hard or calcified artery plaque. A rupture can result in consequences such as arterial damage, the necessity for additional treatments, and even the danger of a heart attack.

Difficulty Navigating Complex Lesions: Angioplasty balloons must travel through the coronary arteries to reach the source of the obstruction. Complex lesions such as those with substantial curvature, extensive calcification, or tortuous paths might present significant obstacles. In such circumstances, the balloon may struggle to move through or may not inflate evenly resulting in inadequate or inefficient treatment.

Restenosis and Recurrent Blockages: Following an angioplasty operation, there is a danger that the treated artery will become blocked again. This could be due to the creation of scar tissue or the regrowth of plaque at the treatment location. Restenosis is a common problem that requires repeat treatments or extra interventions like stenting.

Key Trends:

Technological Improvements: The angioplasty balloon industry is experiencing tremendous technological improvements, resulting in the creation of highly specialized and effective devices. Drug-coated balloons (DCBs) and cutting-edge materials designed to improve performance are examples of innovations. Drug-coated balloons are intended to deliver medication directly to the artery walls during the process, preventing restenosis, which is the re-narrowing of the artery following therapy. This technology improves patients' long-term results after angioplasty.

Rise in Cardiovascular Illnesses: The increasing frequency of cardiovascular illnesses (CVDs) is driving up demand for angioplasty balloons. CVDs including coronary artery disease and peripheral artery disease are becoming increasingly prevalent as a result of lifestyle factors such as poor food, lack of exercise, and rising obesity rates.

Focus on Less Invasive Procedures: In the medical world, there is a rising demand for less invasive procedures, and angioplasty balloons fit right in with this trend. Minimally invasive procedures provide various advantages over standard surgical methods including quicker recovery times, a lower chance of complications, and less post-operative pain.

Global Angioplasty Balloons Market Regional Analysis

Here is a more detailed regional analysis of the global angioplasty balloons market:

North America:

The high prevalence of cardiovascular disease and an aging population are the primary drivers of the North American angioplasty balloons market. The United States leads the regional market due to its advanced healthcare infrastructure and high healthcare spending. The rising incidence of coronary artery disease (CAD) and peripheral artery disease (PAD), the growing use of less invasive procedures, and technological developments in balloon catheter design are all major drivers of the North American angioplasty balloons market.

According to the Centers for Disease Control and Prevention (CDC), heart disease is still the top cause of death in the United States accounting for approximately one out of every four deaths. In 2020, around 697,000 persons in the United States died of heart disease. According to the American Heart Association, coronary heart disease alone accounted for 382,820 deaths in 2020. These statistics highlight the region's significant cardiovascular disease burden which drives demand for angioplasty procedures and, as a result, angioplasty balloons. Another important aspect driving market expansion is the aging population in North America.

Asia Pacific:

The Asia Pacific angioplasty balloons market is expanding rapidly, with China emerging as the fastest-growing market due to its large population and rising frequency of cardiovascular illnesses. This trend is projected to continue in the next years driven by several major variables. The increased incidence of cardiovascular disorders, notably coronary artery disease (CAD) is the key driving force behind the Asia Pacific angioplasty balloons market. According to the World Health Organization (WHO), cardiovascular illnesses account for 31% of all fatalities worldwide with a large proportion occurring in low- and middle-income nations many of which are located in the Asia Pacific region.

Another key driver is the improvement of healthcare infrastructure and increased healthcare spending in several Asia Pacific countries. For example, the Australian Institute of Health and Welfare stated that healthcare spending in Australia reached AUD 185.4 billion in 2017-18, up 3.9% from the year before. In Japan, the Ministry of Health, Labour, and Welfare stated that national medical care expenditure totaled JPY 43.4 trillion in fiscal year 2018, up 0.8% over the previous year. The increased usage of minimally invasive procedures such as angioplasty is also driving market expansion. The Indian Council of Medical Research (ICMR) reported a considerable increase in the number of cardiac catheterization facilities across India allowing for more angioplasty treatments.

Global Angioplasty Balloons Market: Segmentation Analysis

The Global Angioplasty Balloons Market is segmented based on Product Type, Application, Packaging Type, and Geography.

Angioplasty Balloons Market, By Product Type

Normal Ballons

Cutting Ballons

Drug-Eluting Balloons

Based on the Product Type, the Global Angioplasty Balloons Market is bifurcated into Normal Ballons, Cutting Ballons, and Drug-Eluting Balloons. The drug-eluting balloons (DEBs) segment is expected to dominate the angioplasty balloons market. DEBs are favored due to their ability to deliver anti-proliferative drugs directly to the arterial wall reducing the risk of restenosis (re-narrowing of the artery) after the procedure. This feature is particularly crucial in complex cases where restenosis is a common concern. The growing preference for minimally invasive treatments and improved patient outcomes further drives the demand for DEBs making them the dominant product type in the market.

Angioplasty Balloons Market, By Application

Coronary Angioplasty

Peripheral Angioplasty

Based on the Application, the Global Angioplasty Balloons Market is bifurcated into Coronary Angioplasty and Peripheral Angioplasty. The coronary angioplasty segment is dominant in the global angioplasty balloons market primarily due to the high prevalence of cardiovascular diseases (CVDs) such as coronary artery disease (CAD). Coronary angioplasty, a procedure to open blocked or narrowed coronary arteries is widely used to restore blood flow to the heart making it a critical treatment for patients with CAD.

Angioplasty Balloons Market, By End-Users

Hospitals

Ambulatory Surgical Centers

Catheterization Laboratories

Based on the End-Users, the Global Angioplasty Balloons Market is bifurcated into Hospitals, Ambulatory Surgical Centers, and Catheterization Laboratories. In the global angioplasty balloons market, the hospital segment is dominant. Hospitals are the primary setting for angioplasty procedures due to their advanced infrastructure, availability of specialized medical personnel, and the ability to handle complex cases. Hospitals often have dedicated cardiac care units and catheterization laboratories making them the preferred choice for both emergency and elective angioplasty procedures. Additionally, hospitals typically manage a higher volume of patients including those with severe or complicated cardiovascular conditions that require immediate intervention, further driving the demand for angioplasty balloons.

Angioplasty Balloons Market, By Geography

North America

Europe

Asia Pacific

Rest of the World

Based on Geography, the Global Angioplasty Balloons Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The North American region dominates the global angioplasty balloons market primarily due to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and widespread adoption of minimally invasive procedures. The presence of leading medical device companies and strong support for research and development further bolster the market. Additionally, North America benefits from favorable reimbursement policies and a well-established regulatory environment that facilitates the approval and use of angioplasty balloons.

Key Players

The "Global Angioplasty Balloons Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation, Cardinal Health, BIOTRONIK, Cook, ENDOCOR GmbH, B. Braun Melsungen AG.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Angioplasty Balloons Market, By Product Type

• Normal Balloons
• Cutting/Scoring Balloons
• Drug-Eluting Balloons (DEB)

5. Angioplasty Balloons Market, By Application

• Coronary Angioplasty
• Peripheral Angioplasty

6. Angioplasty Balloons Market, By End-Users

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Catheterization Laboratories (Cath Labs)

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic
• Boston Scientific Corporation
• Cordis (Cardinal Health)
• Terumo Corporation
• BIOTRONIK

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References